MRI of the breast

British Journal of Radiology

Volumn 73, Issue 872, 2000, Pages 806-818

  Rankin, S C ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

BIOPSY; BREAST CANCER; BREAST CARCINOMA; CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMPLANT; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREMENOPAUSE; REVIEW; TECHNIQUE; TISSUE DIFFERENTIATION; ULTRASOUND;

EID: 0033847693     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.73.872.11026854     Document Type: Review

References (102)

1. Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging
2. MR imaging of the breast
3. Breast tumours: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent
4. Mammographically occult breast cancer
5. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions
6. Whole-breast US imaging: Four-year follow-up
7. The current role of ultrasonography in breast imaging
8. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions
9. Dynamic gradient-echo and fat suppressed spin echo contrast enhanced MRI of the breast
10. MRI of the breast - Histopathologic correlation
11. Magnetic resonance imaging and spectroscopy of MCF7 human breast cancer. Pathophysiology and monitoring of treatment
12. Benign and malignant breast lesions: Differentiation with echo-planar MR imaging
13. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma
14. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
15. The characteristic angiographic criteria of malignancy
16. Isolation of a tumor factor responsible for angiogenesis
17. Breast lesions; Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis
18. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions
19. Ductal carcinoma in situ: MR imaging-histopathologic correlation
20. Dynamic MRI of invasive breast cancer: Assessment of three region-of-interest analysis methods
21. Primary breast abnormalities: Selective pixel sampling on dynamic gadolinium-enhanced MR images
22. MR imaging of the breast with Gd-DPTA: Use and limitations
23. Signal characteristics of malignant and benign lesions in dynamic 2D-MRI of the breast
24. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
25. Colour doppler in breast diseases
26. Invasive carcinomas and fibroadenomas of the breast: Comparison of microvessel distributions - Implications for imaging modalities
27. Mechanism of contrast enhancement in breast lesions at MR imaging
28. Suspect breast lesions: Findings at dynamic gadolinium enhanced MR imaging correlated with mammographic and pathologic features
29. MR characterization of suspicious breast lesions with a gadolinium-enhanced Turbo FLASH subtraction technique
30. Peripheral enhancement and spatial contrast uptake heterogeneity of primary breast tumours: Quantitative assessment with dynamic MRI
31. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography
32. Breast disease: Dynamic spiral MR imaging
33. Dynamic 3D-MR mammography: Is there a benefit of sophisticated evaluation of enhancement curves for clinical routine?
34. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging
35. Gadopentate dimeglumine-enhanced chemical-shift MR imaging of the breast
36. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation
37. Imaging techniques for breast MR imaging
38. Nonpalpable breast tumors: Diagnosis with contrast-enhanced subtraction dynamic MR imaging
39. Contrast-enhanced MR imaging of the breast: Comparison of two different doses of gadopentate dimeglumine
40. MRI appearance of multiple papilloma of the breast
41. Differentiation of benign from malignant breast masses by time intensity evaluation of contrast enhanced MRI
42. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions
43. Assessment of breast cancer recurrence with contrast-enhanced substraction MR imaging: Preliminary results in 26 patients
44. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions
45. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours
46. Breast MR imaging: Interpretation model
47. Diagnostic potential of ultrafast contrast-enhanced MRI of the breast in hypervascularized lesions: Are there advantages in comparison with standard dynamic MRI
48. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
49. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
50. Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery
51. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy
52. Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent
53. Magnetic resonance imaging and its role in the diagnosis of multicentric breast cancer
54. Breast MR and the appearance of the normal and abnormal nipple
55. Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography
56. Three-dimensional shaded-surface rendering of MR images of the breast: Technique, applications, and impact on surgical management of breast disease
57. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma
58. Breast carcinoma: MR imaging before re-excisional biopsy
59. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer
60. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging
61. Gadopentate dimeglumine-enhanced chemical-shift MR imaging of the breast
62. MR imaging of ductal carcinoma in situ
63. MR imaging of mammographically detected clustered microcalcifications: Is there any value?
64. False-negative MR imaging of malignant breast tumors
65. Ductal carcinoma in situ in dynamic MR-mammography at 1.5T
66. Clustered breast microcalcifications: Evaluation by dynamic contrast-enhanced subtraction MRI
67. Limited value of scinti-mammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography
68. MR imaging of the breast in patients with occult primary breast carcinoma
69. MRI of the breast in patients with metastatic disease of unknown primary
70. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery
71. Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer
72. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma
73. Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer
74. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy
75. MR imaging of the breast in the follow-up evaluation of conservative non operatively treated breast cancer
76. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants
77. Assessment of local recurrence after breast-conserving therapy with MRI
78. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast
79. MRI of breast cancer: Influence of chemotherapy on sensitivity
80. Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy
81. MRI findings in subjects with breast implants
82. Single and double lumen silicone breast implant integrity: Prospective evaluation of MR and US criteria
83. MR imaging of breast implants
84. MR imaging of breast implants
85. Comparative silicone breast implant evaluation using mammography, sonography and magnetic resonance imaging: Experience with 59 implants
86. Magnetic resonance guided localization and biopsy of suspicious breast lesions
87. Menstrual cycle and age: Influence on parenchymal contrast medium enhancement in MR imaging of the breast
88. Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging
89. Menstrual variation of normal breast NMR relaxation parameters
90. Focal and diffuse lesions in dynamic MR-mammography of healthy probands
91. Serendipity in diagnostic imaging: Magnetic resonance imaging of the breast
92. Contrast-enhanced breast MRI: Factors affecting sensitivity and specificity
93. High resolution MR imaging of breast carcinomas and fibroadenomas with radiologic-pathologic correlation
94. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography
95. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up
96. Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography?
97. Magnetic resonance imaging of the breast in characterizing positive or uncertain mammographic findings
98. Sensitivity of enhanced MRI for the detection of breast cancer: New, multicentric, residual, and recurrent
99. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: Are time-signal intensity curves an accurate predictor?
100. High-resolution MR imaging for the detection, diagnosis, and staging of breast cancer
101. Breast magnetic resonance imaging